Kalos Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-152,957
Closed -$2.83M 243
2021
Q4
$2.83M Buy
152,957
+12,629
+9% +$215K 0.77% 20
2021
Q3
$2.59M Sell
140,328
-13,499
-9% -$202K 0.73% 24
2021
Q2
$2.33M Buy
153,827
+5,608
+4% +$70.2K 0.95% 20
2021
Q1
$1.8M Buy
148,219
+46,792
+46% +$566K 0.56% 49
2020
Q4
$1.25M Buy
+101,427
New +$1.09M 0.53% 63

Other funds holding INVA

Kalos Management's INVA Position: Q1 2022 in Review

Kalos Management sold out of Innoviva (INVA) in Q1 2022, closing a stake of 152,957 shares — an estimated $2.83M sold.

Kalos Management first reported a position in INVA in Q4 2020 and held it in 5 quarters. The position peaked at $2.83M in Q4 2021. 236 funds tracked by Wall St. Rank hold INVA as of Q1 2022.

  • Kalos Management reported no remaining Innoviva position as of Q1 2022 after selling out during the quarter.
  • Kalos Management sold 152,957 Innoviva shares in Q1 2022, an estimated $2.83M.
  • Kalos Management first reported a position in Innoviva in Q4 2020 and held it in 5 quarters.
  • Kalos Management's Innoviva position peaked at $2.83M in Q4 2021.
  • 236 funds tracked by Wall St. Rank held Innoviva as of Q1 2022.

Based on Kalos Management's 13F filing for Q1 2022, filed 21 Jun 2022.